Clinical Changes after Switching from Ranibizumab/Aflibercept to Bevacizumab in Exudative Age-related Macular Degeneration.
In Ho Lee, Jae Jung Lee, Han Jo Kwon, Sung Who Park, Ji Eun Lee
J Korean Ophthalmol Soc. 2019;60(1):40-46.   Published online 2019 Jan 15     DOI: https://doi.org/10.3341/jkos.2019.60.1.40
Citations to this article as recorded by Crossref logo
One-year Outcomes of a Treat-and-extend of Ranibizumab for Naive Exudative Age-related Macular Degeneration: Retrospective Analysis
Young-Je Choi, Woong-Sun Yoo, Yong-Wun Cho, Yu-Jin Choi, In Young Chung
Journal of the Korean Ophthalmological Society.2021; 62(7): 939.     CrossRef
Proportion of and Reason for Bevacizumab Usage in the Treatment of Wet Age-related Macular Degeneration
Yi Sang Yoon, Won Tae Yoon, Jong Woo Kim, Chul Gu Kim, Jae Hui Kim
Journal of the Korean Ophthalmological Society.2021; 62(8): 1076.     CrossRef
Ocular Syphilis Presenting as both Optic Neuritis and Chorioretinitis in both Eyes
Won-Jae Kim, Jang-Hwan Ahn, Myung-Mi Kim
Journal of the Korean Ophthalmological Society.2016; 57(5): 857.     CrossRef
A Case of Ocular Syphilis Presenting as Bilateral Optic Neuritis
Hye Jin Lee, Min Jung Kim, Dong Min Cha, Sun Ho Lee, Jin Ho Jeong
Journal of the Korean Ophthalmological Society.2014; 55(7): 1115.     CrossRef